ReviewCancer immunology, immunotherapy : CII2021

Chimeric antigen receptor (CAR)-T-cell therapy in non-small-cell lung cancer (NSCLC): current status and future perspectives.

Jingjing Qu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.